Single-cell Omics Market Growth Driven by Rising Demand for Precision Medicine
Single-cell omics market is driven by the increasing adoption of precision medicine, growing advancements in genomic and proteomic research, and rising demand for detailed cellular analysis in disease diagnosis and treatment development. Technologies such as single-cell genomics, transcriptomics, proteomics, and metabolomics are increasingly being used in oncology, immunology, neurology, and cell biology research to better understand cellular heterogeneity and disease mechanisms. Additionally, increasing investments in biotechnology research, expanding pharmaceutical R&D activities, and growing collaborations between academic institutions and healthcare organizations are further supporting the growth of the global single-cell omics market.
Browse the full report description of “Single-cell omics Market Size, Share & Trends Analysis Report by product Type (Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, and Single-Cell Metabolomics), by Application (Oncology, Cell Biology, Neurology, Immunology and other) and by End user (Pharmaceutical & Biotechnology Companies, Academic and Research Organizations and Hospital and Diagnostic Laboratories), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/single-cell-omics-market
Integrated multiomics and single-cell sequencing segment accounted for a major market share in 2025
Integrated multiomics and single-cell sequencing accounted for a major market share in 2025, primarily due to increasing demand for advanced genomics, proteomics, and AI-driven biological research technologies across life sciences and precision medicine applications. Companies including Illumina, QIAGEN, SomaLogic, and Parse Biosciences actively expanded multiomics capabilities through acquisitions, sequencing platform development, and integrated research workflow expansion. The growing adoption of single-cell analysis, proteomics integration, and scalable omics technologies remained a major factor driving market growth. Rising investments in precision medicine, AI-enabled biology, and next-generation sequencing platforms further supported demand across the single-cell omics industry.
Single-cell omics acquisition and sequencing expansion segment witnessed significant growth in 2024
Single-cell omics acquisition and sequencing expansion witnessed significant growth in 2024, driven by increasing investments in scalable sequencing technologies and integrated single-cell analysis platforms. Illumina completed the acquisition of Fluent BioSciences in July 2024 to strengthen its single-cell omics and multiomics capabilities. The acquisition expanded Illumina’s sequencing ecosystem through scalable single-cell analysis technologies designed to support broader research workflow adoption. Increasing demand for advanced sequencing accuracy, higher throughput analysis, and integrated genomics research accelerated market expansion during the year.
AI-driven biology and scalable single-cell sequencing technologies segment expanded rapidly in 2026
AI-driven biology and scalable single-cell sequencing technologies expanded rapidly in 2026, supported by growing demand for high-throughput RNA sequencing, simplified research workflows, and next-generation omics platforms. Parse Biosciences launched Evercode Whole Transcriptome V4 in February 2026 featuring improved scalability, enhanced sensitivity, and the ability to process up to five million cells in a single run. Additionally, QIAGEN announced the acquisition of Parse Biosciences in November 2025 to strengthen its AI-driven biology, single-cell analysis, and multiomics research capabilities. Increasing adoption of scalable sequencing platforms and AI-powered biological research technologies further supported growth across the single-cell omics market.
About OMR Global
OMR Global is a market intelligence and strategic consulting firm specializing in growth advisory, competitive intelligence, and AI-enabled business research across global B2B industries.
The company supports enterprises, investors, and technology providers with actionable insights for market entry, investment analysis, procurement strategy, commercialization, and business expansion. OMR Global combines industry expertise, primary research, analytics, and digital intelligence tools to help organizations navigate evolving market landscapes and identify growth opportunities.
OMR Digital Offerings
- Pulse Intelligence Platform – AI-powered market intelligence suite designed to deliver analyst-grade insights faster and more efficiently. Built on 12+ years of research expertise and enhanced with AI-driven analytics, Pulse helps organizations transform large volumes of market and company data into actionable intelligence within hours instead of weeks. Trusted by Fortune 500 enterprises, global investment banks, strategy consultancies, and PE & VC firms, Pulse supports strategic decision-making across investment evaluation, competitive benchmarking, AI readiness, and market positioning.
Other Offerings
- Lead Generation – Verified B2B prospect data, ICP targeting, and intent-based sales intelligence
- RFx Support – End-to-end RFP, RFI, and RFQ support with vendor benchmarking and evaluation frameworks
OMR Global delivers data-driven intelligence solutions designed to support strategic decision-making, operational efficiency, and long-term business growth.
To find out more, visit www.omrglobal.com
Contact:
Mr. Anurag Tiwari
305-308, Commerce House, Janjeerwala Square,
Indore, Madhya Pradesh 452001
India
+91-780-304-0404